Autoantibodies to components of the nucleolus are a unique serological feature of patients with scleroderma. There are autoantibodies of several specificities; one type produces a speckled pattern of nucleolar staining in immunofluorescence. In actinomycin D and 5,6-dichloro-,8-D-ribofuranosylbenzimidazoletreated Vero cells, staining was restricted to the fibrillar and not the granular regions. By double immunofluorescence, specific rabbit anti-RNA polymerase I antibodies stained the same fibrillar structures in drug-segregated nucleoli as scleroderma sera. Scleroderma sera immunoprecipitated 13 polypeptides from [35Sjmethionine-labeled HeLa cell extract with molecular weights ranging from 210,000 to 14,000. Similar polypeptides were precipitated by rabbit anti-RNA polymerase I antibodies, and their common identities were confirmed in immunoabsorption experiments. Microinjection of purified IgG from a patient with speckled nucleolar staining effectively inhibited ribosomal RNA transcription. Autoantibodies to RNA polymerase I were restricted to certain patients with scleroderma and were not found in other autoimmune diseases.
Introduction
Patients with systemic autoimmune diseases spontaneously produce antibodies against a variety of cellular components (1) . DNA and histones are among nuclear autoantigens with known structure and function. Other nuclear antigens are either nuclear proteins or RNA-protein complexes that have been partially characterized and called Ul-RNP, Sm, SS-B/La, Jo-i, Scl-70, and centromere/kinetochore antigens (2-10). There are expectations that knowledge of the structure and function of these autoantigens could lead to a better understanding of the etiopathogenesis ofautoimmune diseases and provide better reagents to construct accurate diagnostic probes. Furthermore, some of these naturally occurring autoantibodies have been used successfully as probes in molecular and cellular biology. For example, antibodies against Ul-RNP were shown to inhibit splicing of heterogenous nuclear RNA, thus implicating an important role of this ribonucleoprotein in the processing of precursor mRNA (1 1) . Autoantibodies against SS-B/La identified this nuclear ribonucleoprotein as possibly involved in the transport of RNA, particularly products of RNA polymerase III, including virus encoded RNAs EBER 1 and 2 of Epstein-Barr virus (12) . More recent evidence suggests that the SS-B/La particle is either a termination factor for RNA polymerase III or is involved in posttermination processing events (13) . Recently, anticentromere/kinetochore antibodies from scleroderma patients have facilitated identification and molecular cloning of a common human kinetochore protein (14) .
Antinucleolar antibodies are part of the spectrum of autoantibodies present in scleroderma (15) (16) (17) . This systemic autoimmune disease is characterized by microvascular lesions and abnormalities of the immune system leading to fibrosis of the skin and certain target organs. One of the antigens reactive with scleroderma antibodies was recently shown to be a novel nucleolar 7-2 ribonucleoprotein (18) (19) . U-3 ribonucleoprotein was also shown to be part of a complex precipitated by certain antinucleolar autoantibodies from scleroderma patients (18) . These autoantibodies were found to interact with a basic nucleolar protein of mol wt 34 ,000 (20) , termed fibrillarin, as this protein was shown to be associated with the fibrillar component of nucleoli (21) . The identity of other nucleolar autoantigens in scleroderma, however, is unknown.
In this study, we present data that show that the antigens recognized by a subgroup of antinucleolar autoantibodies consist of RNA polymerase I complex. The clinical association of this antibody specificity was with the diffuse form of scleroderma.
Methods
Sera. Included in this study are sera from 208 scleroderma patients, kindly provided by 0. P (22) . A rabbit antiserum to RNA polymerase I was used as a reference. This antiserum was produced in the laboratory of Dr. K. M. Rose by immunization of a rabbit with purified RNA polymerase I from Morris hepatoma 3924 A in a manner described previously (23) . Rabbit anti-RNA polymerase I antibodies, as used in the present study, had previously been used in a series of other studies to localize RNA polymerase I in normal cells (24) and cells treated with the nucleolus segregating drug 5,6-dichloro-l-D-ribofuranosylbenzimidazole (DRB) (25) . These antibodies had been used further to show induction of increased amount and activity of RNA polymerase I in mouse B lymphocytes treated with lipopolysaccharide (26 (17) .
In the present study, the antigen reactive with scleroderma antibodies that produce speckled nucleolar staining was further characterized.
Localization by light and electron microscopic immunocytochemistry of scleroderma antibodies with speckled nucleolar staining. The following immunofluorescence results were obtained with all nine sera with speckled nucleolar staining. Fig.  1 ______________________________ f stimulated peripheral blood lymphocytes, increased intensity of nucleolar staining was observed in blast-transformed lymphocytes ( Fig. 1 e, large cells). Weak nucleoplasmic staining (+) of interphase cells was also observed with these sera, whereas cytoplasmic staining was usually absent. To further define the nature of the nucleolar antigens, we exposed Vero cells to the nucleolus-segregating drugs actinomycin D and DRB. After drug treatment, cells were processed for indirect immunofluorescence and phase-contrast microscopy. Actinomycin D-inactivated nucleoli show a typical segregation ofthe fibrillar component from the granular component (Fig. 2 b) , with the fibrillar component forming distinct nucleolar hemispheres (31) (32) (33) . Antibodies demonstrating speckled nucleolar staining in untreated cells were now distinctly localized in the fibrillar regions of segregated nucleoli (Fig. 2 a) . Immunofluorescence staining was most prominent in small crescents at the outermost margins of the segregated fibrillar component. Little if any decoration of the granular structures that appeared dark in phase optics was observed. When DRB was added to Vero cells growing in culture, the normally compact nucleoli unraveled into extended beaded strands, segregating the nucleolus into granular and fibrillar regions (34, 35) . Immunofluorescence staining of these cells using the same scleroderma anti- bodies resulted in binding with only fibrillar structures producing a "necklace" distribution of fluorescent dots dispersed throughout the nucleoplasm (Fig. 2, c and d) .
Electron miscroscopy was performed using reference serum S18 and rabbit anti-RNA polymerase I antibodies in the immunogold label technique. In this experiment, gold-antibody complexes were localized in the fibrillar centers of nucleoli in hepatocytes from normal and regenerating rat liver. IgG from scleroderma serum S 18 was selectively enriched over the fibrillar centers and was not observed in the dense fibrillar component or the granular component of nucleoli (Fig. 3, a and b) . The same staining pattern was obtained with a rabbit anti-RNA polymerase I serum (Fig. 3 c) showing distribution of gold-antibody complexes in the fibrillar centers, as had been reported previously (24) .
Interaction ofantinucleolar antibodies from scleroderma sera with RNA polymerase I Double immunofluorescence staining. The enzyme RNA polymerase I has been shown by other investigators to be localized in nucleoli. The immunofluorescence patterns obtained with the human scleroderma sera depicted in Figs. 1 and 2 , as well as the electron microscopic studies in Fig. 3 , are morphologically [35S~methionine-labeled HeLa cell extract with the IgG fraction of rabbit antiserum. We then used this RNA polymerase I-depleted extract in an immunoprecipitation assay and showed that this preparation lacked the antigen recognized by our prototype antinucleolar serum S 18 (Fig. 6, lane 2) . In a reciprocal fashion, when HeLa cell extract was absorbed with this human serum and then probed with rabbit antiserum, the RNA polymerase I complex was not precipitated (Fig. 6, lane 4) . In contrast, depletion of radiolabeled HeLa cell extract by autoantibodies of different immunological specificities, e.g., anti-Sm antibodies as in lane 5, did not affect specific antigen recognition by antinucleolar scleroderma (Fig. 6, lane 6) . This low-percent gel system was used to demonstrate that distinct high molecular weight polypeptides of mol wt 210,000 (PI), 190,000 (P2), 155,000 (P3), 130,000 (P4), 120,000 (P5), and 80,000 (P6) were immunoprecipitated with the rabbit and the human antinucleolar serum.
However, they inhibit transcription of the lampbrush chromosome loops (data not shown). Microinjection of antibodies S18 into the cytoplasm (lane 3) also had no effect on rRNA transcription since antibodies do not migrate through the nuclear pores (36) .
Several attempts were made to identify the epitope or epitopes of the RNA polymerase I complex reactive with certain scleroderma autoantibodies. Extractable whole HeLa cell proteins, isolated nucleoli as well as purified RNA polymerase I from Morris hepatoma 3942A, were electrophoretically transferred to nitrocellulose for immunoblotting. At present, no conclusive results concerning the antigenic subunit were obtained, although a protein of mol wt 190,000 corresponding to one of the large subunits of RNA polymerase I from Morris hepatoma 3924A has been weakly reactive with some sera.
Discussion
In the present study, we have provided evidence by immunocytochemical localization, immunoprecipitation, and microinjection ofautoimmune antibodies into living cells that the RNA (24) . An anti-RNA polymerase I serum from a rabbit was also used in a series of experiments in this study. Double immunofluorescence staining showed that human speckled antinucleolar IgG decorated the same nucleolar structures as the rabbit antibodies. Localization of autoantibodies in the fibrillar regions of drug-segregated nucleoli and, more importantly, their localization by electron microscopy in fibrillar centers (24) , which are the sites of rRNA gene transcription, gave confirming evidence of binding with RNA polymerase I. Interestingly, these scleroderma antibodies produced nucleolar immunofluorescence staining not only in human but also in rodent, avian, and amphibian cells, suggesting that the epitope is highly conserved during evolution. When scleroderma antibodies with speckled nucleolar staining in indirect immunofluorescence were microinjected into X. Iaevis oocytes, a dramatic decrease in the accumulation of newly transcribed ribosomal RNA was observed. The human antibodies thus appear to be effective in interfering with the function of RNA polymerase I.
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On a macromolecular level, both scleroderma antinucleolar antibodies and rabbit anti-RNA polymerase I antibodies immunoprecipitated identical polypeptides ranging from mol wt 210,000 to 14,000. RNA polymerase I is a complex enzyme previously reported to be composed of eight subunits in Morris hepatoma 3942A ranging in size from mol wt 190,000 to 17,500 (23) . By immunoprecipitation with specific antibody, we revealed five additional [35S]methionine-labeled polypeptides present in HeLa cell extract that had not been reported to be part of the enzyme purified by column chromatography from rat hepatoma. Further investigations will determine whether these additional polypeptides are part ofthe RNA polymerase I complex reflecting additional subunits or merely posttranslational modifications of previously described subunits. It is also conceivable that some of these additional polypeptides represent tightly bound factors of this enzyme that may be associated with initiation or termination of rRNA gene transcription (38) , Recently, immunoprecipitation of intrinsically radiolabeled DNA polymerase a with a monoclonal antibody resulted in the identification of an additional catalytic component of this enzyme that had been previously unknown (39) . It seems likely that the use of specific antibody for immunoprecipitation will also facilitate further characterization of RNA polymerase I.
In a previous study, all RNA polymerase I subunits from rat hepatoma could be phosphorylated by an endogenous protein kinase associated with this enzyme (40) (41) . Autoradiography of in vivo 32P-labeled RNA polymerase I obtained by immunoprecipitation in this study revealed only four phosphoproteins (P2, P6, P7, and P 11) as part of the complex. Since the degree ofphosphorylation of this enzyme paralleled transcriptional activity as shown in previous studies (23, 40) (24, 25, 31, 37) , it is difficult to understand why sera from SLE, MCTD, and rheumatoid arthritis patients rarely demonstrate nucleolar staining in indirect immunofluorescence (15) (16) (17) . It The association of speckled nucleolar staining by serum antibodies with the diagnosis of scleroderma was noted in an earlier study (17) . We have extended the studies to show that the reactive antigen demonstrates properties very similar to RNA polymerase I. Our knowledge of the function of this key enzyme in the nucleolus and the further characterization of the epitope may lead to another step in elucidating the immune response in scleroderma.
